Literature DB >> 1386333

The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change.

M Bernardi1, C Di Marco, F Trevisani, C De Collibus, L Fornalé, M Baraldini, P Andreone, C Cursaro, F Zacá, A Ligabue.   

Abstract

To assess the hemodynamic status of patients with compensated cirrhosis, mean arterial pressure, cardiac index and peripheral vascular resistance and markers of central (plasma concentrations of atrial natriuretic factor) and arterial volemia (plasma norepinephrine concentration, plasma renin activity) were studied in 10 patients and 10 healthy control subjects under steady-state conditions (after 2 hr of standing) and after assumption of the supine position (30, 60, and 120 min). After standing, neither hemodynamics nor markers of effective volemia differed significantly between controls and patients. By evaluating the areas under the curve during the 2 hr of supine posture, the increase in cardiac output and plasma natriuretic factor and the decrease in peripheral vascular resistance were greater in patients (2.59 +/- 0.43 [S.E.M.] L/min/hr; 32.8 +/- 7.2 pg/ml/hr -1,103 +/- 248.4 dyn.sec/cm5/hr, respectively) than in controls (0.53 +/- 0.24 L/min/hr, p = 0.005; 17.4 +/- 4.7 pg/ml/hr, p = 0.005; -265.5 +/- 206.2 dyn.sec/cm5/hr, p = 0.02). The declines in heart rate, plasma norepinephrine concentration and plasma renin activity did not differ significantly. Mean arterial pressure did not significantly change. Our results suggest that during periods of upright posture, cirrhotic patients in the preascitic stage, who are known to have expanded blood volume, compensate for dilatation of the splanchnic vascular bed through total hypervolemia. The latter becomes excessive during recumbency, leading to supernormal increases in venous return, central volemia and cardiac index. The decline in peripheral vascular resistance appears to be a compensatory mechanism to maintain steady arterial blood pressure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386333     DOI: 10.1002/hep.1840160210

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

Review 1.  Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

Authors:  Elaine Yeung; Elaine Yong; Florence Wong
Journal:  MedGenMed       Date:  2004-12-02

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications.

Authors:  Giovanni Sansoè; Stefano Silvano; Giulio Mengozzi; Antonina Smedile; Giovanni Touscoz; Floriano Rosina; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

4.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

5.  Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.

Authors:  A Helmy; D E Newby; R Jalan; P C Hayes; D J Webb
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

6.  Reinfusion of concentrated ascitic fluid versus total paracentesis. A randomized prospective trial.

Authors:  A Graziotto; L Rossaro; P Inturri; M Salvagnini
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

7.  Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.

Authors:  N Girgrah; P Liu; J Collier; L Blendis; F Wong
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 8.  Pathophysiology and management of pediatric ascites.

Authors:  Mahmoud Sabri; Miguel Saps; John M Peters
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 9.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture: effects of spironolactone and water immersion.

Authors:  A L Gerbes; A Pilz; H Wernze; D Jüngst
Journal:  Clin Investig       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.